Literature DB >> 29991546

A novel mutation in Wiskott-Aldrich gene manifesting as macrothrombocytopenia and neutropenia.

Mais Arwani1, Daniel Lee2, Abdullah Haddad1, Prerna Mewawalla2.   

Abstract

Wiskott-Aldrich syndrome (WAS) is a rare X-linked disorder, described as a clinical triad of microthrombocytopenia, eczema and recurrent infections. Different mutations in WAS gene have been identified, resulting in various phenotypes and a broad range of disease severity, ranging from classic WAS to X-linked thrombocytopenia and X-linked neutropenia. WAS in some cases can be fatal without haematopoietic stem cell transplantation early in life. In this particular case, we present a novel mutation with a unique presentation. An 18-year-old man incidentally found to have macrothrombocytopenia and neutropenia at 16 years of age later found to be hemizygous for c. 869T>C (p.Ile290Thr) mutation in WAS gene. The late presentation, absence of other manifestations of WAS and presence of macrothrombocytopenia, rather than microthrombocytopenia, which is usually a characteristic finding in WAS, misled the initial diagnosis. On review of literature, this mutation has not been reported as causing WAS. © BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  genetics; malignant and benign haematology

Mesh:

Substances:

Year:  2018        PMID: 29991546      PMCID: PMC6047725          DOI: 10.1136/bcr-2018-225123

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  26 in total

1.  Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea.

Authors:  R A ALDRICH; A G STEINBERG; D C CAMPBELL
Journal:  Pediatrics       Date:  1954-02       Impact factor: 7.124

Review 2.  Wiskott-Aldrich syndrome; an x-linked primary immunodeficiency disease with unique and characteristic features.

Authors:  Tadashi Ariga
Journal:  Allergol Int       Date:  2012-02-25       Impact factor: 5.836

3.  Hereditary X-linked thrombocytopenia maps to the same chromosomal region as the Wiskott-Aldrich syndrome.

Authors:  M Donnér; M Schwartz; K U Carlsson; L Holmberg
Journal:  Blood       Date:  1988-12       Impact factor: 22.113

4.  Wiskott-Aldrich syndrome: qualitative platelet defects and short platelet survival.

Authors:  K A Gröttum; T Hovig; H Holmsen; A F Abrahamsen; M Jeremic; M Seip
Journal:  Br J Haematol       Date:  1969-10       Impact factor: 6.998

5.  Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome.

Authors:  J Litzman; A Jones; I Hann; H Chapel; S Strobel; G Morgan
Journal:  Arch Dis Child       Date:  1996-11       Impact factor: 3.791

Review 6.  Wiskott-Aldrich syndrome: a comprehensive review.

Authors:  Michel J Massaad; Narayanaswamy Ramesh; Raif S Geha
Journal:  Ann N Y Acad Sci       Date:  2013-03-25       Impact factor: 5.691

7.  Novel WASP mutation in a patient with Wiskott-Aldrich syndrome: Case report and review of the literature.

Authors:  M Eghbali; M Sadeghi-Shabestari; F Najmi Varzaneh; A Zare Bidoki; N Rezaei
Journal:  Allergol Immunopathol (Madr)       Date:  2016-03-15       Impact factor: 1.667

8.  The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene.

Authors:  Q Zhu; M Zhang; R M Blaese; J M Derry; A Junker; U Francke; S H Chen; H D Ochs
Journal:  Blood       Date:  1995-11-15       Impact factor: 22.113

9.  Platelet-associated immunoglobulin, platelet size, and the effect of splenectomy in the Wiskott-Aldrich syndrome.

Authors:  L Corash; B Shafer; R M Blaese
Journal:  Blood       Date:  1985-06       Impact factor: 22.113

Review 10.  Inherited thrombocytopenias frequently diagnosed in adults.

Authors:  C L Balduini; A Savoia; M Seri
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

View more
  1 in total

Review 1.  When Actin is Not Actin' Like It Should: A New Category of Distinct Primary Immunodeficiency Disorders.

Authors:  Evelien G G Sprenkeler; Steven D S Webbers; Taco W Kuijpers
Journal:  J Innate Immun       Date:  2020-08-26       Impact factor: 7.349

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.